 Suppression cytomegalovirus retinitis persons AIDS high-dose intravenous acyclovir efficacy safety high-dose intravenous acyclovir oral zidovudine suppressive therapy cytomegalovirus retinitis patients AIDS single-arm outpatient open-label phase II pilot study Between July July men AIDS cytomegalovirus retinitis salvageable vision intravenous acyclovir mg/kg body weight oral zidovudine successful induction therapy intravenous ganciclovir mg/kg days Patients evaluated weekly patients time retinitis progression study concomitant life-threatening infection median duration acyclovir zidovudine therapy retinitis progression days None uninvolved eyes evaluatable patients cytomegalovirus retinitis study participation data high-dose intravenous acyclovir zidovudine benefit cytomegalovirus retinitis